352 related articles for article (PubMed ID: 15239093)
1. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.
Butt AA; Fultz SL; Kwoh CK; Kelley D; Skanderson M; Justice AC
Hepatology; 2004 Jul; 40(1):115-9. PubMed ID: 15239093
[TBL] [Abstract][Full Text] [Related]
2. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
[TBL] [Abstract][Full Text] [Related]
3. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era.
Kramer JR; Giordano TP; Souchek J; El-Serag HB
J Hepatol; 2005 Mar; 42(3):309-14. PubMed ID: 15710213
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.
Anderson KB; Guest JL; Rimland D
Clin Infect Dis; 2004 Nov; 39(10):1507-13. PubMed ID: 15546088
[TBL] [Abstract][Full Text] [Related]
6. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
[TBL] [Abstract][Full Text] [Related]
7. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.
Bräu N; Bini EJ; Shahidi A; Aytaman A; Xiao P; Stancic S; Eng R; Brown ST; Paronetto F
Am J Gastroenterol; 2002 Aug; 97(8):2071-8. PubMed ID: 12190179
[TBL] [Abstract][Full Text] [Related]
9. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
[TBL] [Abstract][Full Text] [Related]
10. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.
Chiao EY; Giordano TP; Richardson P; El-Serag HB
J Clin Oncol; 2008 Jan; 26(3):474-9. PubMed ID: 18202423
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.
Wyatt CM; Arons RR; Klotman PE; Klotman ME
AIDS; 2006 Feb; 20(4):561-5. PubMed ID: 16470120
[TBL] [Abstract][Full Text] [Related]
13. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
McGinnis KA; Fultz SL; Skanderson M; Conigliaro J; Bryant K; Justice AC
J Clin Oncol; 2006 Nov; 24(31):5005-9. PubMed ID: 17075119
[TBL] [Abstract][Full Text] [Related]
16. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
[TBL] [Abstract][Full Text] [Related]
17. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
[TBL] [Abstract][Full Text] [Related]
18. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
19. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; Morsica G; Pizzaferri P; Ladisa N; Sighinolfi L; Chiodera A; Solmone M; Lalle E; Ippolito G; Monforte Ad; ;
Antivir Ther; 2005; 10(1):109-17. PubMed ID: 15751768
[TBL] [Abstract][Full Text] [Related]
20. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]